1. Gavras, I., Gavras, H.: Experimental, clinical, and epidemiological evidence. In: J. I. S. Robertson, M. G. Nicholls (Eds.), The Renin-Angiotensin System, vol. 40 (1993), Gower Medical Publishing, London, p. 1.
2. Belz, G., Fuchs, B., Malerczyk, C., Magin, G., Roll, S.: Inhibition of angiotensin II pressor response and ex vivo angiotensin II radioligand binding by candesartan cilexetil and losartan in healthy human volunteers. J. Hum. Hypertens. 11, S45 (1997).
3. Kenakin, T., Boselli, C.: Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. J. Pharmacol. Exp. Ther. 250(3), 944 (1989).
4. Audi, G., Bersillon, O., Blachot, J., Wapstra, A. H.: The Nubase evaluation of nuclear and decay properties. Nucl. Phys. A. 729(1), 3 (2003).
5. Robbins, J., Schneider, A. B.: Thyroid cancer following exposure to radioactive iodine. Rev. Endocr. Metab. Disord. 1(3), 197 (2000).